Physician profile
Ruben Quintero
NPI 1043219488
$31,566.40
in general payments reported to CMS, 2019-2025
10 companies · $8,908 in 2025
The $8,908 reported for 2025 was more than what 97% of Maternal & Fetal Medicine providers received nationally (typical 2025 total: $55.21).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.22 · 2020: $310 · 2021: $21.35 · 2023: $14K · 2024: $7,843 · 2025: $8,908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $16K · Consulting Fee: $8,825 · Travel and Lodging: $4,197 · Food and Beverage: $1,468 · Education: $500 · Gift: $74.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $16,135.76 |
| Consulting Fee | $8,825.00 |
| Travel and Lodging | $4,196.86 |
| Food and Beverage | $1,467.66 |
| Education | $500.00 |
| Gift | $74.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Samsung Medison Co., Ltd. | $16,958.01 | 2023-2025 | Hera W10 / Sonosync, 2d, Doppler, Mvv-Flow |
| Samsung Hme America, INC. | $13,443.72 | 2023-2025 | |
| Asensus Surgical, INC. | $723.55 | 2023 | Senhance |
| Arthrex, INC. | $155.77 | 2020 | |
| Ge Healthcare | $146.64 | 2020-2021 | |
| Sonio | $74.00 | 2024 | |
| Abbvie INC. | $21.33 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.48 | 2020 | |
| Hologic Sales and Service, LLC | $14.89 | 2019 | |
| Merck Sharp & Dohme LLC | $11.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruben Quintero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.